Last Price  /  Updated: 8:10 PM EST, Mar 6, 2013  /  Add to My Watchlist      
(SOMX) Community Analysis from
April 18, 2014
(Penny Stock DD, 1/28/11)
Clinical Data, Inc. (NASDAQ:CLDA) reported the gain of 5.48% and closed at $26.76 whereas overall traded volume stood at 1.05 million shares for the day. Its outstanding share...(read more)
(Penny Stock DD, 12/2/10)
Jeremy Richards Somaxon Pharmaceuticals (SOMX) looks to be an exceptional bargain buy for new investors given analyst opinions along with zero debt and forward sales expectations. I believe SOMX is...(read more)
(Stock Wizard, 8/25/10)
Somaxon Pharmaceuticals, Inc. (NASDAQ: SOMX)  today announced that Somaxon and Procter & Gamble (NYSE: PG)  have entered into a co-promotion agreement for Silenor(R) (doxepin), a newly-approved...(read more)
Somaxon Pharmaceuticals (SOMX) Company Overview

There is no analysis for SOMX yet. But you can go to Wikinvest to help create one!

What's in this SOMX analysis on Wikinvest...
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here